Send to a Friend Font Size: Increase Decrease

FMS and C2HN34 Related Headlines

Nov 4, 2025 07:00AM Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

FMS and C2HN34 Related Press Releases

Nov 4, 2025 07:00AM Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

FMS and C2HN34 Related SEC Filings